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BACKGROUND
Patient blood management (PBM) must be promoted in orthopedic surgery and
relies on different strategies implemented during the entire perioperative period.
Our aim was to assess whether the introduction of a pre‐, intra‐, and postoperative
PBM protocol combining erythropoietin (EPO), ferric carboxymaltose (FCM), and
tranexamic acid was effective in reducing perioperative transfusion and
postoperative anemia.
STUDY DESIGN AND METHODS
In a two‐phase prospective observational study, all patients admitted for total hip
or knee arthroplasty were included the day before surgery. In Phase 1, use of EPO,
iron, and tranexamic acid was left to the discretion of the anesthesiologists. In
Phase 2, a protocol combining these treatments was implemented in the
perioperative period. Perioperative hemoglobin levels and transfusion rates were
recorded.
RESULTS
A total of 367 patients were included (184 and 183 in Phase 1 and 2, respectively).
During Phase 2, implementing a PBM protocol allowed an increase in preoperative
EPO prescription in targeted patients (i.e., with Hb < 13 g/dL; 18 [38%] vs. 34
[62%], p = 0.03) and in postoperative use of intravenous iron (12 [6%] vs. 32 [18%],
p = 0.001) and tranexamic acid (157 [86%] vs. 171 [94%] patients, p = 0.02). In
Phase 2, the number of patients who received transfusions (24 [13%] vs. 5 [3%],
p = 0.0003) and of patients with a Hb level of less than 10 g/dL at discharge (46
[25%] vs. 26 [14%], p = 0.01) were reduced.
CONCLUSION
Introduction of a PBM protocol, using EPO, FCM, and tranexamic acid, reduces the
number of perioperative transfusions and of patients with a Hb level of less than 10
g/dL at discharge.
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